Now, the new FDA approval means that patients will be able use the ketamine-derived nasal spray, which is marketed under the brand name Spravato, without having to be on another type of ...

He came up with the idea of putting a very small amount of a derivative of ketamine into a nasal spray device. Husseini Manji: It's like an inhaler except it's delivered to the nose. Basically ...

Johnson & Johnson's new nasal spray contains the chemical mirror image of ketamine, which has previously been called a "party drug" because of its quasi-psychedelic effects. On Tuesday ...

The US FDA has approved the first of its kind ketamine-based nasal spray which is supposed to act as a standalone therapy for treatment-resistant depression. No More Pricking: US FDA Approves ...

The FDA has approved Janssen’s antidepressant nasal spray Spravato ... The drug is the first ketamine-based medicine approved to treat depression. Ketamine has long been seen as a potential ...

When Therapy Alone Isn't Enough, Options Like TMS and SPRAVATO® Provide Additional Relief OAK BROOK, Ill., April 8, 2025 ...

The remaining 20% is their coinsurance. S-ketamine, or esketamine (Spravato), is an FDA-approved nasal spray that doctors and healthcare professionals may prescribe for major depressive disorder ...

Ketamine therapy is used in the treatment ... LifeStance Health in Oklahoma also provides nasal spray Spravato (esketamine), another therapeutic option for treatment-resistant depression.

short-acting anesthetic," as well as "a nasal spray for treatment resistant depression" (as esketamine). The FDA first approved ketamine as a short-acting anesthetic for use in humans and animals ...

Ketamine nasal spray and IM injections now available for depression treatment. Ages 18 years and up are welcome for treatment. I accept multiple insurances and cash/credit cards on sliding scale.